Sources et licences

France · Ministère du Travail, de la Santé, des Solidarités et des Familles (ANSM, HAS, Assurance Maladie) · https://base-donnees-publique.medicaments.gouv.fr/telechargement

Lu le 9 octobre 2026 · Fichiers : CIS_bdpm.txt (updated 2026-09-29) ; CIS_CIP_bdpm.txt (updated 2026-10-08) ; CIS_COMPO_bdpm.txt (updated 2026-09-29) ; CIS_HAS_SMR_bdpm.txt, CIS_HAS_ASMR_bdpm.txt and HAS_LiensPageCT_bdpm.txt: HAS Transparency Committee opinions (updated 2026-09-29).

Réutilisation ouverte Licence Ouverte (the download page links to version 1.0, October 2011; the site footer states etalab-2.0) · texte de la licence · conditions

« Vous êtes libres de : Reproduire, diffuser, redistribuer et exploiter les données A condition de : Ne pas altérer les données, ne pas en dénaturer leur sens, mentionner impérativement la source de ces données (base de données publique des médicaments http://base-donnees-publique.medicaments.gouv.fr) et la date de leur mise à jour (Article 12 de la loi n°78-753 du 17 juillet 1978 - loi CADA). »

Attribution requise : Source: base de données publique des médicaments, https://base-donnees-publique.medicaments.gouv.fr, mise à jour du 8 octobre 2026.

Base de données publique des médicaments [Internet]. Paris: Ministère du Travail, de la Santé, des Solidarités et des Familles; 2026 [updated 2026 Oct 8; cited 2026 Oct 9]. Available from: https://base-donnees-publique.medicaments.gouv.fr/telechargement

Espagne · Ministerio de Sanidad · https://www.sanidad.gob.es/profesionales/nomenclator.do

Lu le 9 octobre 2026 · Fichiers : Nomenclátor de Facturación de octubre 2026, Excel download.

Réutilisation ouverte Reuse authorised by the legal notice of the Ministry of Health · texte de la licence · conditions

« La información disponible en este sitio web, salvo indicación expresa en contrario, es susceptible de reutilización; quedando autorizada su reproducción total o parcial, modificación, distribución y comunicación, para usos comerciales y no comerciales, con sujeción a las siguientes condiciones: Queda prohibida en cualquier circunstancia la desnaturalización del contenido de la información. El usuario queda obligado a citar la fuente de los documentos objeto de la reutilización. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización. »

Attribution requise : Fuente: Ministerio de Sanidad, Nomenclátor de facturación de octubre 2026.

Ministerio de Sanidad. Nomenclátor de facturación de octubre 2026 [Internet]. Madrid: Ministerio de Sanidad; 2026 [cited 2026 Oct 9]. Available from: https://www.sanidad.gob.es/profesionales/nomenclator.do

Espagne · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) · https://cima.aemps.es/cima/

Lu le 9 octobre 2026 · Fichiers : CIMA REST service, one record per national code.

Réutilisation ouverte Reproduction authorised by the AEMPS legal notice · texte de la licence · conditions

« Se autoriza la reproducción total o parcial de los contenidos de la web, siempre que se cite expresamente su origen. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización. »

Attribution requise : Fuente: AEMPS, CIMA, consultado el 9 de octubre de 2026.

Agencia Española de Medicamentos y Productos Sanitarios. CIMA: Centro de información de medicamentos [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://cima.aemps.es/cima/

Royaume-Uni · NHS Business Services Authority (NHSBSA) · https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-part-viii

Lu le 9 octobre 2026 · Fichiers : Part VIIIA Oct 2026.csv.

Réutilisation ouverte Open Government Licence · texte de la licence · conditions

« Content from the NHSBSA website is covered by NHSBSA copyright. Visitors can download material in accordance with the Open Government Licence. Should you wish to re-use the information you must include the following statement: "[NHSBSA Title of Information], NHSBSA Copyright [current calendar year]" This information is licenced under the terms of the Open Government Licence. »

Attribution requise : Drug Tariff Part VIIIA October 2026, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

NHS Business Services Authority. Drug Tariff Part VIIIA, October 2026 [Internet]. Newcastle upon Tyne: NHSBSA; 2026 [cited 2026 Oct 9]. Available from: https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/drug-tariff/drug-tariff-part-viii

Royaume-Uni · NHS Business Services Authority (NHSBSA) · https://dmd-browser.nhsbsa.nhs.uk/

Lu le 9 octobre 2026 · Fichiers : VMP and AMPP pages read in a web browser.

À trancher NHSBSA terms and conditions (Open Government Licence), assumed to cover the dm+d browser · texte de la licence · conditions

« Content from the NHSBSA website is covered by NHSBSA copyright. Visitors can download material in accordance with the Open Government Licence. »

à confirmer : le navigateur dm+d ne porte aucune mention de licence propre

Attribution requise : NHS Dictionary of Medicines and Devices (dm+d), NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.

NHS Business Services Authority. dm+d browser: NHS dictionary of medicines and devices [Internet]. Newcastle upon Tyne: NHSBSA; [updated 2026 Oct 1; cited 2026 Oct 9]. Available from: https://dmd-browser.nhsbsa.nhs.uk/

International · WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health · https://atcddd.fhi.no/atc_ddd_index/

Lu le 9 octobre 2026 · Fichiers : One index page per ATC code, for the 20 pilot substances only.

Réutilisation restreinte WHO Collaborating Centre copyright · texte de la licence · conditions

« Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. Copying and distribution for commercial purposes is not allowed. Changing or manipulating the material is not allowed. »

restreinte : ni diffusion commerciale, ni modification ; les DDJ sont donc exclues de la licence CC BY 4.0

Attribution requise : ATC codes and DDDs: WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index 2026.

WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2026 [Internet]. Oslo: Norwegian Institute of Public Health; [updated 2026 Jan 20; cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/atc_ddd_index/

International · WHO Collaborating Centre for Drug Statistics Methodology · https://atcddd.fhi.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/

Lu le 9 octobre 2026.

Citée seulement WHO Collaborating Centre copyright · texte de la licence · conditions

« Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. »

citée seulement

WHO Collaborating Centre for Drug Statistics Methodology. Purpose of the ATC/DDD system [Internet]. Oslo: Norwegian Institute of Public Health; [updated 2018 Feb 7; cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/

International · WHO Collaborating Centre for Drug Statistics Methodology · https://atcddd.fhi.no/ddd/

Lu le 9 octobre 2026.

Citée seulement WHO Collaborating Centre copyright · texte de la licence · conditions

« Use of all or parts of the material requires reference to the WHO Collaborating Centre for Drug Statistics Methodology. »

citée seulement

WHO Collaborating Centre for Drug Statistics Methodology. DDD: definition and general considerations [Internet]. Oslo: Norwegian Institute of Public Health; [cited 2026 Oct 9]. Available from: https://atcddd.fhi.no/ddd/

Union européenne · European Central Bank · https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html

Lu le 9 octobre 2026 · Fichiers : eurofxref-hist-90d.xml, rates of 9 October 2026.

Réutilisation ouverte ECB copyright notice · texte de la licence · conditions

« Subject to the exception below, users of this website may make free use of the information obtained directly from it subject to the following conditions: When such information is distributed or reproduced, it must appear accurately and the ECB must be cited as the source. [...] If the information is modified by the user (e.g. by seasonal adjustment of statistical data or calculation of growth rates) this must be stated explicitly. »

Attribution requise : Exchange rates: European Central Bank, euro reference rates of 9 October 2026.

European Central Bank. Euro foreign exchange reference rates, 9 October 2026 [Internet]. Frankfurt am Main: ECB; 2026 [cited 2026 Oct 9]. Available from: https://www.ecb.europa.eu/stats/policy_and_exchange_rates/euro_reference_exchange_rates/html/index.en.html

Union européenne · European Medicines Agency (EMA) · https://www.ema.europa.eu/en/medicines/download-medicine-data

Lu le 9 octobre 2026 · Fichiers : medicines-output-medicines-report_en.xlsx, generated 9 October 2026, 18:00.

Réutilisation ouverte EMA copyright and limited reproduction notice · texte de la licence · conditions

« Information and documents made available on EMA's webpages are public and may be reproduced and / or distributed, totally or in part, irrespective of the means and / or the formats used, for non-commercial and commercial purposes, provided that EMA is always acknowledged as the source of the material. Such acknowledgement must be included in each copy of the material. »

Attribution requise : Source: European Medicines Agency, medicine data of 9 October 2026, https://www.ema.europa.eu/en/medicines/download-medicine-data

European Medicines Agency. Download medicine data [Internet]. Amsterdam: EMA; 2026 [updated 2026 Oct 9; cited 2026 Oct 9]. Available from: https://www.ema.europa.eu/en/medicines/download-medicine-data

International · DysNet, the dysmelia network · https://www.dysnet.org/knowledge/teratogens/

Lu le 9 octobre 2026 · Fichiers : https://www.dysnet.org/data/teratogens.json, built 12 September 2026.

Réutilisation ouverte Creative Commons Attribution 4.0 International · texte de la licence · conditions

« Download the data (JSON, CC BY 4.0). »

Attribution requise : Teratogen register, DysNet, the dysmelia network, https://www.dysnet.org/knowledge/teratogens/, data built 12 September 2026, CC BY 4.0.

DysNet, the dysmelia network. Teratogen register [Internet]. [place unknown]: DysNet; 2026 [updated 2026 Sep 12; cited 2026 Oct 9]. Available from: https://www.dysnet.org/knowledge/teratogens/

Royaume-Uni · National Institute for Health and Care Excellence (NICE), England · https://www.nice.org.uk/guidance/published?ngt=Technology%20appraisal%20guidance

Lu le 9 octobre 2026 · Fichiers : nice.org.uk search results, one query per medicine.

Réutilisation restreinte NICE terms of use, notice of rights · texte de la licence · conditions

« Except for personal use, study or personal research, copyright content owned by the National Institute for Health and Care Excellence (NICE) may not be used, reproduced, translated, distributed or transmitted in any form, in whole or in part, [...] without the prior written agreement of NICE. »

restreinte : seuls le numéro, le titre, la date et le lien de chaque évaluation sont repris ; le contenu du NICE est exclu de la licence CC BY 4.0

Attribution requise : Source: National Institute for Health and Care Excellence, technology appraisal guidance, https://www.nice.org.uk

National Institute for Health and Care Excellence. Technology appraisal guidance [Internet]. London: NICE; [cited 2026 Oct 9]. Available from: https://www.nice.org.uk/guidance/published?ngt=Technology%20appraisal%20guidance

Royaume-Uni · Scottish Medicines Consortium (SMC), NHS Scotland · https://scottishmedicines.org.uk/medicines-advice/

Lu le 9 octobre 2026 · Fichiers : SMC listing service and advice pages.

Réutilisation restreinte SMC terms and conditions · texte de la licence · conditions

« Scottish Medicines Consortium consents to the photocopying, electronic reproduction by "uploading" or "downloading" from the website, retransmission, or other copying of SMC advice for the purpose of implementation in NHSScotland and educational "not for profit" purposes. No reproduction by or for commercial organisations is permitted without the express written permission of Scottish Medicines Consortium. »

restreinte : avis listés et liés pour une information sans but lucratif ; le contenu du SMC est exclu de la licence CC BY 4.0

Attribution requise : Source: Scottish Medicines Consortium, https://scottishmedicines.org.uk

Scottish Medicines Consortium. Medicines advice [Internet]. Glasgow: SMC; [cited 2026 Oct 9]. Available from: https://scottishmedicines.org.uk/medicines-advice/

International · Gemeinsamer Bundesausschuss (G-BA) · https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/

Lu le 9 octobre 2026 · Fichiers : procedure pages 5, 57 and 132; consolidated decision texts (Geltende Fassung) of 6 September 2012, 20 June 2013 and 19 February 2015.

À trancher G-BA legal notice (Impressum), copyright and linking rules · texte de la licence · conditions

« Der GBA erlaubt und begrüßt ausdrücklich das Zitieren seiner Dokumente sowie das Setzen von Links auf die GBA-Website. Diese Erlaubnis kann jederzeit widerrufen werden und gilt nur, wenn die nachfolgenden Regeln eingehalten sind: Darstellung, dass es sich um Inhalte der Website des GBA handelt (Quellenangabe) [...] Mitteilung an den GBA, dass und von welcher Seite verlinkt wurde »

à faire : citation et liens permis sous conditions, dont signaler au G-BA la page qui pointe vers lui ; le contenu du G-BA est exclu de la licence CC BY 4.0

Attribution requise : Quelle: Gemeinsamer Bundesausschuss, https://www.g-ba.de

Gemeinsamer Bundesausschuss. Nutzenbewertung nach § 35a SGB V: Apixaban [Internet]. Berlin: G-BA; [cited 2026 Oct 9]. Available from: https://www.g-ba.de/bewertungsverfahren/nutzenbewertung/

Espagne · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) · https://www.aemps.gob.es/medicamentos-de-uso-humano/evaluacion-de-tecnologias-sanitarias/informes-de-posicionamiento-terapeutico/

Lu le 9 octobre 2026 · Fichiers : https://www.aemps.gob.es/assets/data/IPT/ddbb.json.

Réutilisation ouverte Reproduction authorised by the AEMPS legal notice · texte de la licence · conditions

« Se autoriza la reproducción total o parcial de los contenidos de la web, siempre que se cite expresamente su origen. El usuario queda obligado a mencionar la fecha de la última actualización de los documentos objeto de la reutilización. »

Attribution requise : Fuente: AEMPS, informes de posicionamiento terapéutico, consultado el 9 de octubre de 2026.

Agencia Española de Medicamentos y Productos Sanitarios. Informes de posicionamiento terapéutico [Internet]. Madrid: AEMPS; [cited 2026 Oct 9]. Available from: https://www.aemps.gob.es/medicamentos-de-uso-humano/evaluacion-de-tecnologias-sanitarias/informes-de-posicionamiento-terapeutico/

International · National Library of Medicine (NLM), National Institutes of Health · https://pubmed.ncbi.nlm.nih.gov/

Lu le 9 octobre 2026 · Fichiers : NCBI E-utilities esearch and esummary, one set of queries per medicine.

Réutilisation ouverte NLM terms and conditions for its data · texte de la licence · conditions

« Users of the data agree to: acknowledge NLM as the source of the data by including the phrase "Courtesy of the U.S. National Library of Medicine" in a clear and conspicuous manner, not indicate or imply that NLM has endorsed its products/services/applications. »

Attribution requise : Courtesy of the U.S. National Library of Medicine.

PubMed [Internet]. Bethesda (MD): National Library of Medicine (US); [cited 2026 Oct 9]. Available from: https://pubmed.ncbi.nlm.nih.gov/

International · World Health Organization · https://list.essentialmeds.org/

Lu le 9 octobre 2026 · Fichiers : eEML list and one page per recommendation; binding PDF lists of 2025: EML https://iris.who.int/handle/10665/382243, EMLc https://iris.who.int/handle/10665/382242.

Réutilisation ouverte Creative Commons Attribution 3.0 IGO · texte de la licence · conditions

« eEML contents are available under the Creative Commons Attribution CC BY 3.0 IGO. »

Attribution requise : WHO Model List of Essential Medicines, electronic version (eEML), World Health Organization, CC BY 3.0 IGO.

World Health Organization. Electronic Essential Medicines List (eEML) [Internet]. Geneva: WHO; [cited 2026 Oct 9]. Available from: https://list.essentialmeds.org/

France · Caisse nationale de l'assurance maladie (Assurance Maladie) · http://www.codage.ext.cnamts.fr/codif/tips/index.php?p_site=AMELI

Lu le 9 octobre 2026 · Fichiers : LPP905.zip (DBF files, version 905 of 8 October 2026) ; code records (fiches) read on the same site.

À trancher No licence stated on the LPP site · conditions

à trancher : aucune licence trouvée ; la réutilisation reposerait sur les règles françaises de réutilisation des informations publiques

Attribution requise : Source : Assurance Maladie, liste des produits et prestations, version 905 du 8 octobre 2026.

Assurance Maladie. Liste des produits et prestations (LPP), version 905 [Internet]. Paris: Caisse nationale de l'assurance maladie; 2026 [updated 2026 Oct 8; cited 2026 Oct 9]. Available from: http://www.codage.ext.cnamts.fr/codif/tips/index.php?p_site=AMELI

États-Unis · Centers for Medicare & Medicaid Services (CMS) · https://www.cms.gov/medicare/payment/fee-schedules/dmepos/dmepos-fee-schedule/dme26-d

Lu le 9 octobre 2026 · Fichiers : dme26-d.zip, DMEPOS_OCT.csv.

Réutilisation ouverte Public domain (US federal government work) · texte de la licence · conditions

« CMS.gov is the official website of the Centers for Medicare & Medicaid Services (CMS), an operating division of the U.S. Department of Health & Human Services (HHS). It is a public domain web site. »

Attribution requise : Source: CMS, DMEPOS fee schedule, October 2026.

Centers for Medicare & Medicaid Services. DMEPOS fee schedule, October 2026 (DME26-D) [Internet]. Baltimore (MD): CMS; 2026 [cited 2026 Oct 9]. Available from: https://www.cms.gov/medicare/payment/fee-schedules/dmepos/dmepos-fee-schedule/dme26-d

États-Unis · Centers for Medicare & Medicaid Services (CMS) · https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update

Lu le 9 octobre 2026 · Fichiers : october-2026-alpha-numeric-hcpcs-file.zip.

Réutilisation ouverte Public domain (US federal government work) · texte de la licence · conditions

« It is a public domain web site. »

Attribution requise : Source: CMS, HCPCS Level II file, October 2026.

Centers for Medicare & Medicaid Services. October 2026 alpha-numeric HCPCS file [Internet]. Baltimore (MD): CMS; 2026 [cited 2026 Oct 9]. Available from: https://www.cms.gov/medicare/coding-billing/healthcare-common-procedure-system/quarterly-update

Australie · Office of Parliamentary Counsel, Federal Register of Legislation (instrument made by the Department of Health, Disability and Ageing) · https://www.legislation.gov.au/F2026L00773/latest/text

Lu le 9 octobre 2026 · Fichiers : F2026L00773, Volume 2.

Réutilisation ouverte Creative Commons Attribution 4.0 International · texte de la licence · conditions

« With the exception of the Commonwealth Coat of Arms, and where otherwise noted, all content on the Federal Register of Legislation (the Legislation Register) is provided under Creative Commons Attribution 4.0 International (the CC BY 4.0 licence). »

Attribution requise : Based on content from the Federal Register of Legislation at 9 October 2026. For the latest information on Australian Government legislation please go to https://www.legislation.gov.au.

Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No. 3) 2026 (Cth) [Internet]. Canberra: Federal Register of Legislation; 2026 Jun 22 [cited 2026 Oct 9]. F2026L00773. Available from: https://www.legislation.gov.au/F2026L00773/latest/text

Australie · Department of Health, Disability and Ageing · https://www.health.gov.au/topics/private-health-insurance/what-private-health-insurance-covers/medical-devices-and-human-tissue-products-covered-under-private-health-insurance

Lu le 9 octobre 2026.

Réutilisation restreinte Commonwealth of Australia copyright (department website) · texte de la licence · conditions

« Except where otherwise indicated, you can download, display, print and reproduce the whole or part of this content in unaltered form for: your own personal use internal use within your organisation. [...] You must not reproduce, frame or reformat the files, pages, images, information and materials from this website on any other website unless express written permission has been obtained from us. »

restreinte : citée et paraphrasée seulement, jamais reproduite

Department of Health, Disability and Ageing. Medical devices and human tissue products covered under private health insurance [Internet]. Canberra: Australian Government; [updated 2025 Mar 13; cited 2026 Oct 9]. Available from: https://www.health.gov.au/topics/private-health-insurance/what-private-health-insurance-covers/medical-devices-and-human-tissue-products-covered-under-private-health-insurance

Union européenne · European Commission, Directorate-General for Health and Food Safety · https://webgate.ec.europa.eu/dyna2/emdn/

Lu le 9 octobre 2026 · Fichiers : EMDN v2026_EN.xlsx.

À trancher Creative Commons Attribution 4.0 International (Commission reuse policy, Decision 2011/833/EU) · texte de la licence · conditions

« Unless otherwise indicated (e.g. in individual copyright notices), content owned by the EU on this website is licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. This means that reuse is allowed, provided appropriate credit is given and changes are indicated. »

à confirmer : la mention citée est celle de commission.europa.eu ; le portail EMDN annonce un accès gratuit sans licence propre

Attribution requise : EMDN: European Commission, European Medical Device Nomenclature, version 2026.

European Commission. European Medical Device Nomenclature (EMDN), version 2026 [Internet]. Brussels: European Commission; 2026 [cited 2026 Oct 9]. Available from: https://webgate.ec.europa.eu/dyna2/emdn/